News
March 18, 2024:
Instanosis has been awarded a new NIH Blue Print Medtech Small Business Translator SBIR grant for developing a rapid urine xylazine test device.
March 18, 2024:
Instanosis has been awarded a new NIH fast track SBIR grant for developing a rapid urine fentanyl test device.
October 24, 2023:
Instanosis’s InstaStrip-Fentanyl Rapid Test has been granted Breakthrough Device designation by the United States Food and Drug Administration (FDA).
November 17, 2023:
Instanosis publishes a paper on the rapid detection of fentanyl and its analogs using a novel chemiluminescence imunoassay
June 20, 2023:
Instanosis has successfully implemented Quality Management System, compliant with FDA requirements
June 16, 2023:
Instanosis is awarded a Small Business Innovation Research grant supplement from the NIH to develop lateral flow assays for rapid fentanyl detection
June 06, 2023:
Instanosis is awarded a Small Business Technology Transfer Grant from the NIH to use smartphones to reduce prostate cancer monitoring disparities
August 22, 2022:
Instanosis is awarded a Small Business Innovation Research Grant from the NIH to develop lateral flow assays for rapid fentanyl detection